Mark E. Bunnage
Impact in
- Organic Chemistry top 1%
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
- Click Chemistry and Applications
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Chemical Synthesis and Analysis
- Histone Deacetylase Inhibitors Research
Papers in
-
- Synthetic Organic Chemistry Methods 12
- Asymmetric Synthesis and Catalysis 7
-
- Protein Degradation and Inhibitors 9
- Chemical Synthesis and Analysis 6
- Co-authors
- Lyn H. Jones (4 shared papers)Stephen G. Davies (11 shared papers)Eugene L. Piatnitski Chekler (1 shared paper)Christopher J. Goodwin (7 shared papers)Kyriacos Costa Nicolaou (9 shared papers)Kazunori Koide (6 shared papers)S. Picaud (3 shared papers)Stefan Knapp (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of Medicinal Chemistry (8 papers)Chemistry - A European Journal (6 papers)Nature Chemical Biology (5 papers)Organic & Biomolecular Chemistry (4 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark E. Bunnage
64 papers receiving 4.3k citations
Mark E. Bunnage's Hit Papers
Peers
Comparison fields: 5 of 128
- Organic Chemistry 1.5k
- Molecular Biology 2.8k
- Hematology 452
- Computational Theory and Mathematics 518
- Pharmaceutical Science 152
Countries citing papers authored by Mark E. Bunnage
This map shows the geographic impact of Mark E. Bunnage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Bunnage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Bunnage more than expected).
Fields of papers citing papers by Mark E. Bunnage
This network shows the impact of papers produced by Mark E. Bunnage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Bunnage. The network helps show where Mark E. Bunnage may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Bunnage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The promise and peril of chemical probes Hit paper breakdown → | 2015 | 670 |
| 2 | 2013 | 350 | |
| 3 | 2014 | 249 | |
| 4 | 2013 | 222 | |
| 5 | 2011 | 208 | |
| 6 | 2012 | 177 | |
| 7 | 2014 | 154 | |
| 8 | 2017 | 144 | |
| 9 | Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants Hit paper breakdown → | 2023 | 144 |
| 10 | 2015 | 131 | |
| 11 | 2015 | 114 | |
| 12 | 1994 | 95 | |
| 13 | 1999 | 88 | |
| 14 | 2016 | 87 | |
| 15 | 2015 | 86 | |
| 16 | 2011 | 82 | |
| 17 | 1999 | 73 | |
| 18 | 2010 | 72 | |
| 19 | 1994 | 63 | |
| 20 | 1994 | 62 |
About Mark E. Bunnage
Mark E. Bunnage is a scholar working on Organic Chemistry, Molecular Biology, Hematology, Pharmacology and Physiology, having authored 64 papers that have together received 4.5k indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (12 papers), Protein Degradation and Inhibitors (9 papers), Asymmetric Synthesis and Catalysis (7 papers), Asthma and respiratory diseases (6 papers), Chemical Synthesis and Analysis (6 papers), Microbial Natural Products and Biosynthesis (5 papers), Computational Drug Discovery Methods (5 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Organic Chemistry (1.5k citations), Molecular Biology (2.8k citations), Hematology (452 citations), Computational Theory and Mathematics (518 citations) and Pharmaceutical Science (152 citations). Mark E. Bunnage has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Lyn H. Jones, Stephen G. Davies, Eugene L. Piatnitski Chekler, Christopher J. Goodwin, Kyriacos Costa Nicolaou, Kazunori Koide, S. Picaud, Stefan Knapp, P. Filippakopoulos and Martin Philpott. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Chemistry - A European Journal, Nature Chemical Biology and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.